Skip to content

One of the cornerstones of TAG’s work is weighing in on mission-related issues by sending comment letters to a variety of organizations, including Federal agencies, Senate and House committees, Pharmaceutical companies, and the WHO. Various staff members also frequently testify in person at committee hearings, and submit written testimony.

2024 Letters

Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council
May 28, 2024 — These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.

TAG Comments at UN High-Level Meeting on Antimicrobial Resistance Hearing
May 15, 2024 — TAG delivered an intervention at the UN High-Level Meeting on Antimicrobial Resistance (AMR) Multistakeholder Hearing, calling on member states to incorporate drug-resistant TB (DR-TB) in the political declaration as a key component of AMR response.

Comments In Regard to NIAID’S Strategic Plan, May 2024
May 13, 2024 — Treatment Action Group submitted comments in response to “Request for Information (RFI): Inviting Comments and Suggestions on NIAID’s Strategic Plan” highlighting the organization’s key priorities across the NIAID portfolio.

Archives:
Back To Top